Biochem/physiol Actions
Primary Targetcathepsin L
Reversible: yes
Product does not compete with ATP.
Target IC50: 1.9 nM against Cathepsin L
Cell permeable: yes
General description
A potent, cell-permeable, selective, and reversible inhibitor of cathepsin L (IC50 = 1.9 nM). Inhibits the release of Ca2+ and hydroxyproline from bone in a bone culture system and prevents bone loss in ovariectomized mice (~50 mg/kg).
A potent, cell-permeable, selective, and reversible inhibitor of cathepsin L (IC50 = 1.9 nM). Also inhibits the release of Ca2+ and hydroxyproline from bone in an in vitro bone culture system and prevents bone loss in ovariectomized mice (~50 mg/kg).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Yasuma, T., et al. 1998. J. Med. Chem. 41, 4301.
Packaging
1 mg in Plastic ampoule
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Sequence
1-Naphthalenesulfonyl-Ile-Trp-CHO
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: